Full metadata record
DC FieldValueLanguage
dc.contributor.authorHsu, John T. -A.en_US
dc.contributor.authorYeh, Jiann-Yihen_US
dc.contributor.authorLin, Ta-Jenen_US
dc.contributor.authorLi, Mei-lingen_US
dc.contributor.authorWu, Ming-Sianen_US
dc.contributor.authorHsieh, Chung-Fanen_US
dc.contributor.authorChou, Yao Chiehen_US
dc.contributor.authorTang, Wen-Fangen_US
dc.contributor.authorLau, Kean Sengen_US
dc.contributor.authorHung, Hui-Chenen_US
dc.contributor.authorFang, Ming-Yuen_US
dc.contributor.authorKo, Shengkaien_US
dc.contributor.authorHsieh, Hsing-Pangen_US
dc.contributor.authorHorng, Jim-Tongen_US
dc.date.accessioned2014-12-08T15:21:24Z-
dc.date.available2014-12-08T15:21:24Z-
dc.date.issued2012-02-01en_US
dc.identifier.issn0066-4804en_US
dc.identifier.urihttp://dx.doi.org/10.1128/AAC.00125-11en_US
dc.identifier.urihttp://hdl.handle.net/11536/15230-
dc.description.abstractThe aim of this study was to identify the antiviral mechanism of a novel compound, BPR3P0128. From a large-scale screening of a library of small compounds, BPR3P compounds were found to be potent inhibitors of influenza viral replication in Madin-Darby canine kidney (MDCK) cells. BPR3P0128 exhibited inhibitory activity against both influenza A and B viruses. The 50% inhibitory concentrations were in the range of 51 to 190 nM in MDCK cells, as measured by inhibition-of-cytopathic-effect assays. BPR3P0128 appeared to target the viral replication cycle but had no effect on viral adsorption. The inhibition of cap-dependent mRNA transcription by BPR3P0128 was more prominent with a concurrent increase in cap-independent cRNA replication in a primer extension assay, suggesting a role of BPR3P0128 in switching transcription to replication. This reduction in mRNA expression resulted from the BPR3P-mediated inhibition of the cap-dependent endoribonuclease (cap-snatching) activities of nuclear extracts containing the influenza virus polymerase complex. No inhibition of binding of 5' viral RNA to the viral polymerase complex by this compound was detected. BPR3P0128 also effectively inhibited other RNA viruses, such as enterovirus 71 and human rhinovirus, but not DNA viruses, suggesting that BPR3P0128 targets a cellular factor(s) associated with viral PB2 cap-snatching activity. The identification of this factor(s) could help redefine the regulation of viral transcription and replication and thereby provide a potential target for antiviral chemotherapeutics.en_US
dc.language.isoen_USen_US
dc.titleIdentification of BPR3P0128 as an Inhibitor of Cap-Snatching Activities of Influenza Virusen_US
dc.typeArticleen_US
dc.identifier.doi10.1128/AAC.00125-11en_US
dc.identifier.journalANTIMICROBIAL AGENTS AND CHEMOTHERAPYen_US
dc.citation.volume56en_US
dc.citation.issue2en_US
dc.citation.spage647en_US
dc.citation.epage657en_US
dc.contributor.department生物科技學系zh_TW
dc.contributor.departmentDepartment of Biological Science and Technologyen_US
dc.identifier.wosnumberWOS:000299658900007-
dc.citation.woscount13-
Appears in Collections:Articles


Files in This Item:

  1. 000299658900007.pdf

If it is a zip file, please download the file and unzip it, then open index.html in a browser to view the full text content.